 |
|
|
|
 |
Maura N. Dickler, MD
I am a board-certified medical oncologist whose clinical practice is devoted to the care of patients with breast cancer, and I work as part of a multidisciplinary team to treat women with this disease. My research activities are focused on developing new therapeutic approaches to both preventing and treating breast cancer.
Currently, I am involved in clinical trials to evaluate anti-angiogenic agents, which are designed to cut off the tumor’s blood supply. In addition, I am investigating therapies that interfere with estrogen in women with hormone-receptor positive breast cancer, and therapies that are targeted to estrogen and growth factor signaling pathways. My colleagues and I are investigating these approaches when they are given together, as well as in combination (anti-estrogen therapy and anti-angiogenic therapy) as well as in combination with hormonal agents and chemotherapy.
I am a member of a number of medical groups including the New York Metropolitan Breast Cancer Group, the American Society of Clinical Oncology (ASCO), and the American College of Physicians/American Society of Internal Medicine. I also serve on the National Cancer Institute sponsored Cancer and Leukemia Group B (CALGB) Breast Committee, the ASCO Breast Cancer Education Committee, and the Susan G. Komen Foundation’s Promise Grants Scientific Peer Review Committee.
I am a reviewer for several clinical journals including The Lancet, the New England Journal of Medicine, Journal of Clinical Oncology, Clinical Cancer Research, and Breast Cancer Research and Treatment. I have written more than 20 peer-reviewed articles, review articles, and book chapters.
Appointments for New Patients
646-497-9064
Phone
646-888-5456
Education
MD, The University of Chicago Pritzker School of Medicine
Residencies
The University of Chicago Hospitals
Fellowships
Memorial Sloan-Kettering Cancer Center
Board Certifications
Internal Medicine; Medical Oncology
Clinical Expertise
Breast Cancer
Department & Service
|
|
|
|
|
|
